A proposal to dramatically increase the number of patients that a practitioner can treat at any one time with buprenorphine is under review by the White House Office of Management and Budget. OMB review is typically the last step in the regulatory process before a final rule is published in the Federal Register. Final action on the rule remains scheduled for September, according t... Read More